Pharmacy Times » Biosimilars
300 FOLLOWERS
Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy. Pharmacy Times is the leading media resource for pharmacists and the pharmacy industry,..
Pharmacy Times » Biosimilars
2h ago
Secondhand exposure to e-cigarette smoke may increase risk of pediatric atopic dermatitis in children ..read more
Pharmacy Times » Biosimilars
18h ago
The FDA approved blinatumomab for treatment of patients with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia ..read more
Pharmacy Times » Biosimilars
21h ago
Mim8 had a safe and well-tolerated profile, with no deaths or thrombotic events reported for patients with hemophilia A ..read more
Pharmacy Times » Biosimilars
21h ago
With this approval, Yimmugo is the first approved product from the Biotest Next Level production facility ..read more
Pharmacy Times » Biosimilars
21h ago
Creating a supportive environment and staying informed on the latest research can be significant when supporting patients in the LGBTQ+ community, notes Olivia Buckoski, PharmD, AAHIVP, HIVPCP ..read more
Pharmacy Times » Biosimilars
1d ago
PBMs are Leeches: First video spot explains pharmacy benefit managers' role in higher drug prices ..read more
Pharmacy Times » Biosimilars
1d ago
Since 1997, Pharmacy Times has compiled these results to collect the most up-to-date information about which brands pharmacists recommend most often to patients ..read more
Pharmacy Times » Biosimilars
1d ago
Persistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders ..read more
Pharmacy Times » Biosimilars
1d ago